annual EBITDA:
$65.03M+$82.08M(+481.15%)Summary
- As of today (September 16, 2025), INSP annual EBITDA is $65.03 million, with the most recent change of +$82.08 million (+481.15%) on December 31, 2024.
- During the last 3 years, INSP annual EBITDA has risen by +$103.65 million (+268.35%).
- INSP annual EBITDA is now at all-time high.
Performance
INSP EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
$98.00K-$1.46M(-93.71%)Summary
- As of today (September 16, 2025), INSP quarterly EBITDA is $98.00 thousand, with the most recent change of -$1.46 million (-93.71%) on June 30, 2025.
- Over the past year, INSP quarterly EBITDA has dropped by -$6.38 million (-98.49%).
- INSP quarterly EBITDA is now -99.71% below its all-time high of $34.36 million, reached on December 31, 2024.
Performance
INSP quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
$52.19M-$6.38M(-10.90%)Summary
- As of today (September 16, 2025), INSP TTM EBITDA is $52.19 million, with the most recent change of -$6.38 million (-10.90%) on June 30, 2025.
- Over the past year, INSP TTM EBITDA has increased by +$63.26 million (+571.43%).
- INSP TTM EBITDA is now -10.90% below its all-time high of $58.57 million, reached on March 31, 2025.
Performance
INSP TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
INSP EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +481.1% | -98.5% | +571.4% |
| 3 y3 years | +268.4% | +100.7% | +232.9% |
| 5 y5 years | +312.6% | +100.4% | +193.1% |
INSP EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +259.6% | -99.7% | +100.5% | -10.9% | +204.0% |
| 5 y | 5-year | at high | +220.1% | -99.7% | +100.4% | -10.9% | +191.6% |
| alltime | all time | at high | +220.1% | -99.7% | +100.4% | -10.9% | +191.6% |
INSP EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | $98.00K(-93.7%) | $52.19M(-10.9%) |
| Mar 2025 | - | $1.56M(-95.5%) | $58.57M(+37.4%) |
| Dec 2024 | $65.03M(-481.2%) | $34.36M(+112.5%) | $42.63M(+131.9%) |
| Sep 2024 | - | $16.17M(+149.4%) | $18.39M(-266.1%) |
| Jun 2024 | - | $6.48M(-145.1%) | -$11.07M(-66.6%) |
| Mar 2024 | - | -$14.38M(-242.2%) | -$33.16M(-11.4%) |
| Dec 2023 | -$17.06M(-58.1%) | $10.11M(-176.1%) | -$37.42M(-20.4%) |
| Sep 2023 | - | -$13.29M(-14.9%) | -$47.04M(-6.2%) |
| Jun 2023 | - | -$15.61M(-16.2%) | -$50.18M(+4.8%) |
| Mar 2023 | - | -$18.64M(-3858.1%) | -$47.90M(+7.2%) |
| Dec 2022 | -$40.73M(+5.5%) | $496.00K(-103.0%) | -$44.69M(-3.7%) |
| Sep 2022 | - | -$16.42M(+23.2%) | -$46.41M(+18.2%) |
| Jun 2022 | - | -$13.33M(-13.6%) | -$39.27M(+3.3%) |
| Mar 2022 | - | -$15.44M(+1170.5%) | -$38.01M(+0.4%) |
| Dec 2021 | -$38.62M(-28.6%) | -$1.22M(-86.9%) | -$37.86M(-12.4%) |
| Sep 2021 | - | -$9.29M(-23.0%) | -$43.23M(-0.3%) |
| Jun 2021 | - | -$12.07M(-21.0%) | -$43.38M(-19.2%) |
| Mar 2021 | - | -$15.28M(+132.3%) | -$53.68M(-1.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2020 | -$54.13M(+77.0%) | -$6.58M(-30.3%) | -$54.41M(-4.5%) |
| Sep 2020 | - | -$9.44M(-57.8%) | -$56.97M(+1.6%) |
| Jun 2020 | - | -$22.38M(+39.8%) | -$56.05M(+34.3%) |
| Mar 2020 | - | -$16.01M(+75.2%) | -$41.74M(+21.3%) |
| Dec 2019 | -$30.59M(+68.7%) | -$9.14M(+7.3%) | -$34.40M(+14.5%) |
| Sep 2019 | - | -$8.52M(+5.6%) | -$30.05M(+15.2%) |
| Jun 2019 | - | -$8.07M(-7.0%) | -$26.09M(+10.7%) |
| Mar 2019 | - | -$8.67M(+81.0%) | -$23.55M(+17.9%) |
| Dec 2018 | -$18.13M(+17.2%) | -$4.79M(+5.3%) | -$19.98M(+6.3%) |
| Sep 2018 | - | -$4.55M(-17.9%) | -$18.80M(+5.8%) |
| Jun 2018 | - | -$5.54M(+8.5%) | -$17.77M(+7.6%) |
| Mar 2018 | - | -$5.11M(+41.4%) | -$16.51M(+6.7%) |
| Dec 2017 | -$15.47M(-9.6%) | -$3.61M(+2.6%) | -$15.47M(+30.4%) |
| Sep 2017 | - | -$3.52M(-17.7%) | -$11.86M(+42.2%) |
| Jun 2017 | - | -$4.28M(+5.3%) | -$8.34M(+105.3%) |
| Mar 2017 | - | -$4.06M | -$4.06M |
| Dec 2016 | -$17.12M(-12.9%) | - | - |
| Dec 2015 | -$19.65M | - | - |
FAQ
- What is Inspire Medical Systems, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Inspire Medical Systems, Inc.?
- What is Inspire Medical Systems, Inc. annual EBITDA year-on-year change?
- What is Inspire Medical Systems, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Inspire Medical Systems, Inc.?
- What is Inspire Medical Systems, Inc. quarterly EBITDA year-on-year change?
- What is Inspire Medical Systems, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Inspire Medical Systems, Inc.?
- What is Inspire Medical Systems, Inc. TTM EBITDA year-on-year change?
What is Inspire Medical Systems, Inc. annual EBITDA?
The current annual EBITDA of INSP is $65.03M
What is the all time high annual EBITDA for Inspire Medical Systems, Inc.?
Inspire Medical Systems, Inc. all-time high annual EBITDA is $65.03M
What is Inspire Medical Systems, Inc. annual EBITDA year-on-year change?
Over the past year, INSP annual EBITDA has changed by +$82.08M (+481.15%)
What is Inspire Medical Systems, Inc. quarterly EBITDA?
The current quarterly EBITDA of INSP is $98.00K
What is the all time high quarterly EBITDA for Inspire Medical Systems, Inc.?
Inspire Medical Systems, Inc. all-time high quarterly EBITDA is $34.36M
What is Inspire Medical Systems, Inc. quarterly EBITDA year-on-year change?
Over the past year, INSP quarterly EBITDA has changed by -$6.38M (-98.49%)
What is Inspire Medical Systems, Inc. TTM EBITDA?
The current TTM EBITDA of INSP is $52.19M
What is the all time high TTM EBITDA for Inspire Medical Systems, Inc.?
Inspire Medical Systems, Inc. all-time high TTM EBITDA is $58.57M
What is Inspire Medical Systems, Inc. TTM EBITDA year-on-year change?
Over the past year, INSP TTM EBITDA has changed by +$63.26M (+571.43%)